Market News & Analysis

Top Story

CDC warning sends shivers across European markets

European stocks are being sold off heavily after Wall Street had a historically bad day triggered by the warning from the US Centre for Disease Control that the US is at risk of the coronavirus spread. Investors were frantically trying to access how high the toll of a US spread would be, including company closures, supply disruptions and a hit to consumer confidence, but for the moment there is no reliable model to base it on, particularly as China approached containing the virus in a different fashion than other countries.

In Europe the virus is beginning to get a grip with 34 new cases in Italy registered in the last 24 hours and the first cases reported in Spain and Croatia. And yet, as the virus mushrooms across Europe, for China the worst may be close to over. France-listed luxury goods maker Hermes has been one of the international blue chips to say that its operations in the country are returning to normal and that it has reopened all but four of its 43 shops in China, Hong Kong and Macau.

On the FTSE the worst hit were travel operators, airlines and the London Stock Exchange group itself.

Brent slumps ahead of OPEC

The spread of the coronavirus also pummeled Brent crude prices which are now trading around the $53.3 mark. Even before the latest decline an OPEC technical committee suggested that the cartel should lower its output further by another 600,000 bbl. Events will likely force OPEC members' hands when they meet in Vienna next week, making a cut as good as an inevitability.


This report is intended for general circulation only. It should not be construed as a recommendation, or an offer (or solicitation of an offer) to buy or sell any financial products. The information provided does not take into account your specific investment objectives, financial situation or particular needs. Before you act on any recommendation that may be contained in this report, independent advice ought to be sought from a financial adviser regarding the suitability of the investment product, taking into account your specific investment objectives, financial situation or particular needs.

GAIN Capital Singapore Pte. Ltd., may distribute reports produced by its respective foreign entities or affiliates within the GAIN Capital group of companies or third parties pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed to a person in Singapore who is not an accredited investor, expert investor or an institutional investor (as defined in the Securities Futures Act), GAIN Capital Singapore Pte. Ltd. accepts legal responsibility to such persons for the contents of the report only to the extent required by law. Singapore recipients should contact GAIN Capital Singapore Pte. Ltd. at 6826 9988 for matters arising from, or in connection with the report.

In the case of all other recipients of this report, to the extent permitted by applicable laws and regulations neither GAIN Capital Singapore Pte. Ltd. nor its associated companies will be responsible or liable for any loss or damage incurred arising out of, or in connection with, any use of the information contained in this report and all such liability is hereby expressly disclaimed. No representation or warranty is made, express or implied, that the content of this report is complete or accurate.

GAIN Capital Singapore Pte. Ltd. is not under any obligation to update this report.

Trading CFDs and FX on margin carries a high level of risk that may not be suitable for some investors. Consider your investment objectives, level of experience, financial resources, risk appetite and other relevant circumstances carefully. The possibility exists that you could lose some or all of your investments, including your initial deposits. If in doubt, please seek independent expert advice. Visit for the complete Risk Disclosure Statement.

Important Notice:

Cryptocurrencies are not legal tender currency and trading of derivatives on Cryptocurrencies are currently not covered under any regulatory regime in Singapore. Consequently, investors should be aware they do not have protection under the Securities and Futures Act (Cap. 289). Please ensure that you are fully aware of the risks.